WHWK EBITDA | WHITEHAWK THERAPEUTICS, INC.

WHITEHAWK THERAPEUTICS, INC. (WHWK) EBITDA

2026-06-30: Basis Reported; EBITDA (m); Operating income -$18.11M; Depreciation and amortization (m).
2026-03-31: Basis Reported; EBITDA (m); Operating income -$23.52M; Depreciation and amortization (m).
2025-09-30: Basis Reported; EBITDA (m); Operating income -$19.55M; Depreciation and amortization (m).
2025-06-30: Basis Reported; EBITDA (m); Operating income -$54.75M; Depreciation and amortization (m).

Complete source-backed ebitda history.

Available history: 2020-12-31 to 2025-12-31
Data captured: 2026-09-04

Historical EBITDA

EBITDA 3 month

Date	Basis	EBITDA	Operating income	Depreciation and amortization	Revenue	EBITDA margin	Capital spending	Operating cash flow	Cost of products and services	Research and development	Selling, general and administration	Income tax expense / benefit
2026-06-30	Reported	(m)	-$18.11M	(m)	$0.00	(m)	$0.00*	-$14.53M*	$0.00	$12.89M	$5.22M	$0.00
2026-03-31	Reported	(m)	-$23.52M	(m)	$0.00	(m)	$0.00	-$22.21M	$0.00	$17.23M	$6.29M	$0.00
2025-09-30	Reported	(m)	-$19.55M	(m)	$0.00	(m)	$0.00*	-$15.38M*	$0.00	$14.35M	$5.20M	$0.00
2025-06-30	Reported	(m)	-$54.75M	(m)	$0.00	(m)	$1.00K*	-$52.96M*	$0.00	$48.81M	$5.94M	$0.00
2025-03-31	Reported	(m)	-$15.22M	(m)	$7.14M	(m)	$551.00K	-$11.86M	$760.00K	$8.79M	$12.81M	$0.00
2024-09-30	Reported	(m)	-$13.41M	(m)	$7.21M	(m)	$188.00K*	-$15.69M*	$804.00K	$10.00M	$7.19M	$0.00
2024-06-30	Reported	(m)	-$15.58M	(m)	$6.18M	(m)	$541.00K*	-$9.16M*	$778.00K	$13.09M	$7.89M	$0.00
2024-03-31	Reported	-$19.46M	(m)	(m)	(m)	-363.57%	$739.00K	-$19.65M	$652.00K	$13.59M	$10.62M	$0.00
2023-12-31	Reported	-$17.67M	(m)	(m)	(m)	-279.32%	(m)	(m)	(m)	(m)	(m)	(m)
2023-09-30	Reported	-$17.80M*	-$17.85M	$44.00K*	$5.96M	-298.79%*	$1.10M*	-$11.95M*	$697.00K	$11.89M	$11.22M	$0.00
2023-06-30	Reported	-$19.50M*	-$19.55M	$43.00K*	$6.20M	-314.45%*	$689.00K*	-$16.76M*	$656.00K	$13.31M	$11.78M	$0.00
2023-03-31	Reported	-$16.79M	(m)	(m)	(m)	-286.13%	$1.37M	-$21.31M	$529.00K	$10.96M	$11.21M	$0.00
2022-12-31	Reported	-$15.43M	(m)	(m)	(m)	-295.12%	(m)	(m)	(m)	(m)	(m)	(m)
2022-09-30	Reported	-$15.02M*	-$15.04M	$12.00K*	$4.25M	-353.92%*	$102.00K*	-$8.20M*	$593.00K	$8.77M	$9.91M	$0.00
2022-06-30	Reported	-$18.33M*	-$18.36M	$27.00K*	$3.44M	-533.40%*	$241.00K*	-$10.72M*	$341.00K	$7.73M	$10.01M	$9.00K
2022-03-31	Reported	-$13.74M	(m)	(m)	(m)	-595.58%	$23.00K	-$19.41M	$179.00K	$6.79M	$9.15M	$0.00
2021-12-31	Reported	-$15.87M	(m)	(m)	(m)	-114.36%	(m)	(m)	(m)	(m)	(m)	(m)
2021-09-30	Reported	-$87.28M*	-$87.31M	$29.00K*	$0.00	(m)	$0.00*	-$17.37M*	$0.00	$5.75M	$7.40M	$0.00
2021-06-30	Reported	-$3.87M*	-$3.88M	$2.00K*	$0.00	(m)	(m)	-$3.19M*	$0.00	$3.04M	$830.00K	$2.00K
2021-03-31	Reported	-$4.09M	(m)	(m)	(m)	-3404.17%	(m)	$10.56M	(m)	$3.64M	$563.00K	(m)
2020-12-31	Reported	$8.41M	(m)	(m)	(m)	61.95%	(m)	(m)	(m)	(m)	(m)	(m)
2020-09-30	Reported	(m)	-$2.66M	(m)	$231.00K	(m)	$6.83K*	-$15.78M*	(m)	$2.40M	(m)	$1.00K
2020-06-30	Reported	(m)	$9.26M	(m)	$15.00M	(m)	(m)	$10.29M*	(m)	$3.55M	(m)	(m)
2020-03-31	Reported	(m)	-$4.11M	(m)	(m)	(m)	(m)	-$3.94M	(m)	$1.83M	(m)	(m)
2019-12-31	Reported	(m)	-$4.66M	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2019-09-30	Reported	(m)	-$4.97M	(m)	(m)	(m)	$4.28K*	-$4.76M*	(m)	$2.84M	(m)	(m)
2019-06-30	Reported	(m)	-$5.98M	(m)	(m)	(m)	$119.39K*	-$5.15M*	(m)	$2.26M	(m)	(m)
2019-03-31	Reported	(m)	-$8.84M	(m)	(m)	(m)	$113.28K	-$9.08M	(m)	$5.59M	(m)	(m)
2018-12-31	Reported	(m)	-$8.87M	(m)	$2.14K	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2018-09-30	Reported	(m)	$11.20M	(m)	$18.82M	(m)	$20.88K*	-$6.22M*	(m)	$4.35M	(m)	(m)
2018-06-30	Reported	(m)	-$6.04M	(m)	$1.33M	(m)	$0.00*	$13.11M*	(m)	$4.23M	(m)	(m)
2018-03-31	Reported	(m)	-$7.48M	(m)	(m)	(m)	$8.50K	-$6.51M	(m)	$4.03M	(m)	(m)
2017-12-31	Reported	(m)	-$6.29M	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2017-09-30	Reported	(m)	-$4.76M	(m)	(m)	(m)	$0.00*	-$4.02M*	(m)	$2.94M	(m)	(m)
2017-06-30	Reported	(m)	-$5.58M	(m)	(m)	(m)	$4.34K*	(m)	(m)	$3.17M	(m)	(m)
2017-03-31	Reported	(m)	-$4.76M	(m)	(m)	(m)	$2.21K	(m)	(m)	$2.26M	(m)	(m)
2016-12-31	Reported	(m)	-$3.31M	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2016-09-30	Reported	(m)	-$4.75M	(m)	(m)	(m)	$0.00*	-$12.44K*	(m)	$3.48M	(m)	(m)
2016-06-30	Reported	(m)	-$4.38M	(m)	(m)	(m)	$2.85K*	-$2.95K*	(m)	$2.90M	(m)	(m)
2016-03-31	Reported	(m)	-$4.21M	(m)	(m)	(m)	$110.45K	-$5.30K	(m)	$2.99M	(m)	(m)
2015-09-30	Reported	(m)	-$4.33K	(m)	(m)	(m)	(m)	-$3.83K*	(m)	(m)	(m)	(m)
2015-06-30	Reported	(m)	-$5.10K	(m)	(m)	(m)	(m)	-$13.19K*	(m)	(m)	(m)	(m)
2015-03-31	Reported	(m)	-$3.96K	(m)	(m)	(m)	(m)	-$1.98K	(m)	(m)	(m)	(m)
2014-09-30	Reported	(m)	-$4.76K	(m)	(m)	(m)	(m)	-$1.70K*	(m)	(m)	(m)	(m)
2014-06-30	Reported	(m)	-$5.31K	(m)	(m)	(m)	(m)	-$1.31K*	(m)	(m)	(m)	(m)
2014-03-31	Reported	(m)	-$4.14K	(m)	(m)	(m)	(m)	-$400.00	(m)	(m)	(m)	(m)
2013-09-30	Reported	(m)	-$4.47K	(m)	(m)	(m)	(m)	-$8.13K*	(m)	(m)	(m)	(m)
2013-06-30	Reported	(m)	-$5.46K	(m)	(m)	(m)	(m)	-$9.29K*	(m)	(m)	(m)	(m)
2013-03-31	Reported	(m)	-$4.81K	(m)	(m)	(m)	(m)	-$1.90K	(m)	(m)	(m)	(m)
2012-09-30	Reported	(m)	-$4.75K	(m)	(m)	(m)	(m)	-$3.92K*	(m)	(m)	(m)	(m)
2012-06-30	Reported	(m)	-$5.03K	(m)	(m)	(m)	(m)	-$14.29K*	(m)	(m)	(m)	(m)
2012-03-31	Reported	(m)	-$4.23K	(m)	(m)	(m)	(m)	-$5.53K	(m)	(m)	(m)	(m)
2011-09-30	Reported	(m)	-$5.43K	(m)	(m)	(m)	(m)	-$3.10K*	(m)	(m)	(m)	(m)
2011-06-30	Reported	(m)	-$5.86K	(m)	(m)	(m)	(m)	-$15.40K*	(m)	(m)	(m)	(m)
2011-03-31	Reported	(m)	-$4.27K	(m)	(m)	(m)	(m)	-$2.26K	(m)	(m)	(m)	(m)
2010-09-30	Reported	(m)	-$4.24K	(m)	(m)	(m)	(m)	-$3.51K*	(m)	(m)	(m)	(m)
2010-06-30	Reported	(m)	-$5.12K	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)

EBITDA 12 month

Date	Basis	EBITDA	Operating income	Depreciation and amortization	Revenue	EBITDA margin	Capital spending	Operating cash flow	Cost of products and services	Research and development	Selling, general and administration	Income tax expense / benefit
2025-12-31	Reported	-$114.32M	(m)	(m)	(m)	-1600.01%	$552.00K	-$97.43M	$760.00K	$90.96M	$29.82M	$0.00
2024-12-31	Reported	-$67.27M	(m)	(m)	(m)	-258.88%	$1.65M	-$59.55M	$3.02M	$51.03M	$36.75M	$0.00
2023-12-31	Reported	-$71.76M	(m)	(m)	(m)	-294.67%	$3.97M	-$59.66M	$2.81M	$48.93M	$44.55M	$0.00
2022-12-31	Reported	-$62.52M	(m)	(m)	(m)	-410.90%	$444.00K	-$49.64M	$1.33M	$32.66M	$40.18M	$0.00
2021-12-31	Reported	-$111.11M	(m)	(m)	(m)	-793.66%	$46.00K	-$22.42M	$0.00	$19.67M	$18.51M	$2.00K
2020-12-31	Reported	-$2.54M	(m)	(m)	(m)	-18.14%	$19.02K	-$12.70M	(m)	$15.01M	(m)	$2.00K
2020-09-30	Rolling	(m)	-$2.18M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2020-06-30	Rolling	(m)	-$4.48M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2020-03-31	Rolling	(m)	-$19.72M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2019-12-31	Reported	(m)	-$24.44M	(m)	$0.00	(m)	$236.95K	-$23.85M	(m)	$12.82M	(m)	(m)
2019-12-31	Rolling	(m)	-$24.44M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2019-09-30	Rolling	(m)	-$28.65M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2019-06-30	Rolling	(m)	-$12.49M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2019-03-31	Rolling	(m)	-$12.55M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2018-12-31	Reported	(m)	-$11.18M	(m)	$20.16M	(m)	$37.91K	-$5.81M	(m)	$17.85M	(m)	(m)
2018-12-31	Rolling	(m)	-$11.18M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2018-09-30	Rolling	(m)	-$8.60M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2018-06-30	Rolling	(m)	-$24.56M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2018-03-31	Rolling	(m)	-$24.11M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2017-12-31	Reported	(m)	-$21.39M	(m)	(m)	(m)	$8.90K	-$18.88M	(m)	$12.15M	(m)	(m)
2017-12-31	Rolling	(m)	-$21.39M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2017-09-30	Rolling	(m)	-$18.41M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2017-06-30	Rolling	(m)	-$18.39M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2017-03-31	Rolling	(m)	-$17.19M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2016-12-31	Reported	(m)	-$16.63M	(m)	(m)	(m)	$113.30K	-$24.52K	(m)	$11.37M	(m)	(m)
2016-12-31	Rolling	(m)	-$16.63M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2015-12-31	Reported	(m)	-$23.01K	(m)	(m)	(m)	(m)	-$21.73K	(m)	(m)	(m)	(m)
2014-12-31	Reported	(m)	-$23.97K	(m)	(m)	(m)	(m)	-$16.02K	(m)	(m)	(m)	(m)
2013-12-31	Reported	(m)	-$22.82K	(m)	(m)	(m)	(m)	-$23.32K	(m)	(m)	(m)	(m)
2012-12-31	Reported	(m)	-$22.39K	(m)	(m)	(m)	(m)	-$24.52K	(m)	(m)	(m)	(m)
2011-12-31	Reported	(m)	-$23.59K	(m)	(m)	(m)	(m)	-$22.77K	(m)	(m)	(m)	(m)
2010-12-31	Reported	(m)	-$20.51K	(m)	(m)	(m)	(m)	-$19.24K	(m)	(m)	(m)	(m)

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
Eledon Pharmaceuticals, Inc. (ELDN)	United States	$0.219B	-3.23
NATURES SUNSHINE PRODUCTS INC (NATR)	United States	$0.228B	20.51
Foghorn Therapeutics Inc. (FHTX)	United States	$0.213B	-4.43
Keros Therapeutics, Inc. (KROS)	United States	$0.229B	-2.55
Cartesian Therapeutics, Inc. (RNAC)	United States	$0.231B	-2.04
SIGA TECHNOLOGIES INC (SIGA)	United States	$0.234B	-93.33
Sionna Therapeutics, Inc. (SION)	United States	$0.236B	-20.37
Nkarta, Inc. (NKTX)	United States	$0.205B	-1.73
Camp4 Therapeutics Corp (CAMP)	United States	$0.240B	-2.12
MACROGENICS INC (MGNX)	United States	$0.242B	-20.11